Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
Authors
Keywords
-
Journal
INVESTIGATIONAL NEW DRUGS
Volume 30, Issue 6, Pages 2201-2209
Publisher
Springer Nature
Online
2012-01-09
DOI
10.1007/s10637-011-9790-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EGFR-mutated lung cancer: a paradigm of molecular oncology
- (2015) Oncotarget
- Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer
- (2015) Rodrigo Dienstmann et al. Oncotarget
- The Hsp90 chaperone machinery: from structure to drug development
- (2011) Ji-Sook Hahn BMB Reports
- Lung cancer: New biological insights and recent therapeutic advances
- (2011) Suresh S. Ramalingam et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Crizotinib: an anaplastic lymphoma kinase inhibitor
- (2011) Shirish M Gadgeel et al. Future Oncology
- Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy
- (2011) W. Ying et al. MOLECULAR CANCER THERAPEUTICS
- A MEK-independent role for CRAF in mitosis and tumor progression
- (2011) Ainhoa Mielgo et al. NATURE MEDICINE
- Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling
- (2011) David A. Proia et al. PLoS One
- Global Patterns of Cancer Incidence and Mortality Rates and Trends
- (2010) A. Jemal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Maintenance Therapy for Advanced Non-small Cell Lung Cancer: Current Status, Controversies, and Emerging Consensus
- (2010) T. K. Owonikoko et al. CLINICAL CANCER RESEARCH
- Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements
- (2010) Shivanni Kummar et al. NATURE REVIEWS DRUG DISCOVERY
- Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens
- (2010) F. Grossi et al. ONCOLOGIST
- Beyond Doublet Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Combination of Targeted Agents with First-Line Chemotherapy
- (2009) Roy S. Herbst et al. Clinical Lung Cancer
- New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential
- (2009) Yanyan Li et al. DRUG RESISTANCE UPDATES
- Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non-small cell lung cancer
- (2009) R. Bao et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Hsp90 Down-regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel
- (2008) A. Sawai et al. CANCER RESEARCH
- Heat Shock Protein 90 as a Drug Target: Some Like It Hot
- (2008) U. Banerji CLINICAL CANCER RESEARCH
- Targeting Hsp90: small-molecule inhibitors and their clinical development
- (2008) Tony Taldone et al. CURRENT OPINION IN PHARMACOLOGY
- Mitotic catastrophe cell death induced by heat shock protein 90 inhibitor in BRCA1-deficient breast cancer cell lines
- (2008) M. Zajac et al. MOLECULAR CANCER THERAPEUTICS
- Systemic Chemotherapy for Advanced Non-Small Cell Lung Cancer: Recent Advances and Future Directions
- (2008) S. Ramalingam et al. ONCOLOGIST
- Development and application of Hsp90 inhibitors
- (2007) D SOLIT DRUG DISCOVERY TODAY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now